Discontinuation report MYLAN-OMEPRAZOLE
Report ID | 52267 |
Drug Identification Number | 02329425 |
Brand name | MYLAN-OMEPRAZOLE |
Common or Proper name | OMEPRAZOLE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OMEPRAZOLE |
Strength(s) | 10MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL |
Packaging size | 30 BT |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-09-03 |
Actual discontinuation date | 2018-08-16 |
Remaining supply date | 2018-08-16 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Discontinued in shortage ID 235. Last lot sold: 3085385. exp Feb 28, 2019 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-08-28 | French | Compare |
v9 | 2018-08-28 | English | Compare |
v8 | 2018-08-27 | French | Compare |
v7 | 2018-08-27 | English | Compare |
v6 | 2018-08-27 | French | Compare |
v5 | 2018-08-27 | English | Compare |
v4 | 2018-08-27 | English | Compare |
v3 | 2018-06-12 | French | Compare |
v2 | 2018-06-12 | English | Compare |
v1 | 2018-06-12 | English | Compare |
Showing 1 to 10 of 10